MedPath

Dental sensitivity toothpastes: a clinical safety and effectiveness investigation conducted on healthy adult participants.

Not Applicable
Conditions
Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified
Registration Number
CTRI/2024/07/071115
Lead Sponsor
Dabur India Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Age will be 18 to 65 years (both inclusive) old at the time of consent.

2)Sex will be Healthy adult males and non-pregnant/non-lactating females.

3)Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc.

4)Subjects are generally in good general health as determined from recent medical history.

5)Subjects with a plaque index and gingivitis index score greater than 1 during screening.

6)Subjects having hypersensitive tooth during screening.

7)Subjects having root caries at time of screening.

8)Subjects having 6 present upper front teeth.

9)Anterior teeth without restorations.

10)No previous treatments performed on tooth.

11)Subjects who agree to discontinue the use of over-the-counter any teeth products throughout the trial.

12)Subjects who agree to refrain from the use of any oral products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.).

13)Agree not to participate in any other oral/dental product studies during the trial.

14)Agree to return for all scheduled visits and follow study procedures.

15)Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.

Exclusion Criteria

1)Subjects who are undergoing treatment for gingivitis, caries, dental plaque and sensitivity.

2)Subjects are present with fixed orthodontic appliances on the facial surfaces of the maxillary arch.

3)Subjects have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth (canine to canine) or mandibular anterior teeth.

4)Subjects have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised.

5)Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.

6)Subjects have meaningful malocclusion that would impact treatment or ease of viewing/scoring anterior teeth.

7)Subjects have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypo calcification.

8)Subjects have any known allergies to over-the-counter oral hygiene/ products.

9)Subjects have any known allergies to the trial product ingredients.

10)The subject must have participated in a clinical study with oral care or oral hygiene within 4 weeks before the screening visit of this study.

11)Any other condition which could warrant exclusion from the study, as per the investigator’s discretion.

12) Subjects who smoke and are pan eaters.

13) Subjects with hypersensitive teeth and with mobility greater than one as per miller tooth

mobility index.

14) Subjects having chipped teeth and defective restorations.

15) Subjects having deep periodontal pockets.

16) Subjects having bridgework in their teeth and dentures which interrupt during evaluation.

17) Subjects undergoing periodontal surgery within previous 6 months.

18) Subjects undergoing treatment with antibiotics, anti-inflammatory, anticonvulsants, anti histaminic, anti-depressant, anti-histaminic, sedatives, tranquilizers or daily analgesic drugs.

19) Subjects having uncontrolled metabolic disease.

20) Subjects overexposure to acidic by dietary and environment exposure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath